Glucagon-Like Peptide-1 (Glp-1) Analogs Are A Group Of Medications That Are Used For Treating Type 2 Diabetes
Glucagon-Like Peptide-1 (Glp-1) Analogs Glucagon-Like Peptide-1 Analogs are newer drugs used to treat type 2 diabetes. They regulate glucose levels by stimulating insulin secretion, suppressing glucagon release, and promoting satiety. These effects help control blood sugar, which can help prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function disorders. Several studies have shown that GLP-1 can also improve lipid metabolism, suppress appetite, and increase fat loss in obese patients. These effects may lead to weight loss and improvement of blood glucose control in type 2 diabetes patients. According to Coherent Market Insights the Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. GLP-1 is produced by three different tissues, which include the enteroendocrine L cells of the distal intestine, alpha cells in the central nervous system, and the pancreas. It acts on the GLP-1 rec